Cargando…
Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665237/ http://dx.doi.org/10.1182/blood-2022-159213 |
| _version_ | 1784831246696710144 |
|---|---|
| author | Sanz-Linares, Gabriela Mussetti, Alberto Albasanz-Puig, Adaia Salvador-Corre, Iñaki Sureda, Anna Gudiol, Carlota Salazar, Ramon Marin, Mar García Martín, Margarita Navarro, Valentin De la Haba, Irma Coma, Eva Dura, Xavier Fontanals, Sandra Serrano, Gala Cruz, Claudia Mañez, Rafael Moreno-González, Gabriel |
| author_facet | Sanz-Linares, Gabriela Mussetti, Alberto Albasanz-Puig, Adaia Salvador-Corre, Iñaki Sureda, Anna Gudiol, Carlota Salazar, Ramon Marin, Mar García Martín, Margarita Navarro, Valentin De la Haba, Irma Coma, Eva Dura, Xavier Fontanals, Sandra Serrano, Gala Cruz, Claudia Mañez, Rafael Moreno-González, Gabriel |
| author_sort | Sanz-Linares, Gabriela |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9665237 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96652372022-11-16 Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study Sanz-Linares, Gabriela Mussetti, Alberto Albasanz-Puig, Adaia Salvador-Corre, Iñaki Sureda, Anna Gudiol, Carlota Salazar, Ramon Marin, Mar García Martín, Margarita Navarro, Valentin De la Haba, Irma Coma, Eva Dura, Xavier Fontanals, Sandra Serrano, Gala Cruz, Claudia Mañez, Rafael Moreno-González, Gabriel Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665237/ http://dx.doi.org/10.1182/blood-2022-159213 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Abstracts Sanz-Linares, Gabriela Mussetti, Alberto Albasanz-Puig, Adaia Salvador-Corre, Iñaki Sureda, Anna Gudiol, Carlota Salazar, Ramon Marin, Mar García Martín, Margarita Navarro, Valentin De la Haba, Irma Coma, Eva Dura, Xavier Fontanals, Sandra Serrano, Gala Cruz, Claudia Mañez, Rafael Moreno-González, Gabriel Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study |
| title | Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study |
| title_full | Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study |
| title_fullStr | Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study |
| title_full_unstemmed | Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study |
| title_short | Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study |
| title_sort | phase i clinical trial to evaluate the safety of baricitinib to prevent respiratory insufficiency progression in oncohematological patients affected with covid-19 - barcovid19 study |
| topic | Poster Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665237/ http://dx.doi.org/10.1182/blood-2022-159213 |
| work_keys_str_mv | AT sanzlinaresgabriela phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT mussettialberto phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT albasanzpuigadaia phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT salvadorcorreinaki phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT suredaanna phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT gudiolcarlota phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT salazarramon phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT marinmar phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT garciamartinmargarita phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT navarrovalentin phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT delahabairma phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT comaeva phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT duraxavier phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT fontanalssandra phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT serranogala phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT cruzclaudia phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT manezrafael phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study AT morenogonzalezgabriel phaseiclinicaltrialtoevaluatethesafetyofbaricitinibtopreventrespiratoryinsufficiencyprogressioninoncohematologicalpatientsaffectedwithcovid19barcovid19study |